Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours
Open Access
- 1 January 2012
- journal article
- Published by E-MED LTD in Cancer Imaging
- Vol. 12 (2) , 351-360
Abstract
Stereotactic ablative body radiotherapy (SABR) represents a technological breakthrough in radiotherapy technique, with proven benefits to patients in terms of improved tumour control and overall survival. The key components of SABR are described. ...Keywords
This publication has 45 references indexed in Scilit:
- Role of positron emission tomography computed tomography in carcinoma lung evaluationJournal of Cancer Research and Therapeutics, 2011
- Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung CancerJAMA, 2010
- An Overview of Hypofractionation and Introduction to This Issue of Seminars in Radiation OncologySeminars in Radiation Oncology, 2008
- Outcomes of Risk-Adapted Fractionated Stereotactic Radiotherapy for Stage I Non–Small-Cell Lung CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non–small-cell lung cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: Phase I studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Survival of 2,991 Patients With Surgical Lung CancerChest, 2005
- The Influence of Hospital Volume on Survival after Resection for Lung CancerNew England Journal of Medicine, 2001
- Long-term results of lung metastasectomy: Prognostic analyses based on 5206 casesThe Journal of Thoracic and Cardiovascular Surgery, 1997
- The Norton-Simon hypothesis revisited.1986